EODData

MEMBERSHIP REGISTER LOG IN

FRA, 8CC: COCRYSTAL PHARMA NEW O.N.

16 Jul 2026
LAST:

0.8100

CHANGE:
 0.02		OPEN:
0.8100		HIGH:
0.8100		ASK:
0.0000		VOLUME:
0
CHG(%):
1.89		PREV:
0.7950		LOW:
0.8100		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Jul 260.81000.81000.81000.81000
15 Jul 260.79500.79500.79500.79500
14 Jul 260.81500.81500.81500.81500
13 Jul 260.85500.85500.85500.85500
10 Jul 260.85500.85500.85500.85500
09 Jul 260.83500.83500.83500.83500
08 Jul 260.86500.86500.86500.86500
07 Jul 260.88000.88000.88000.88000
06 Jul 260.88500.88500.88500.88500
03 Jul 260.88000.88000.88000.88000

PROFILE

Name:COCRYSTAL PHARMA NEW O.N.
About:Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, a HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was founded in 2006 and is based in Bothell, Washington.
Sector:Healthcare
Industry:Biotechnology
Address:19805 North Creek Parkway, Bothell, WA, United States, 98011
Website:https://www.cocrystalpharma.com
ISIN:US19188J4094

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-1.10 
PEG Ratio:0.04 
Price to Sales:51.17 
Price to Book:3.19 
Operating Margin:-10.47 
Return on Assets:-0.62 
Return on Equity:-1.55 
Revenue:197.3K 
Shares:10.26M 
Market Cap:8.31M 

TECHNICAL INDICATORS

MA5:0.832.0%
MA10:0.854.6%
MA20:0.855.3%
MA50:0.9112.9%
MA100:0.9517.5%
MA200:0.9314.5%
STO9:16.67 
STO14:14.29 
RSI14:27.91 
WPR14:-85.71 
MTM14:-0.09
ROC14:-0.10 
ATR:0.02 
Week High:0.865.6%
Week Low:0.801.9%
Month High:0.9111.7%
Month Low:0.7914.5%
Year High:2.80245.7%
Year Low:0.7114.9%
Volatility:39.67 

RECENT SPLITS

Date Ratio
11 Oct 20221-12